Rats are one of the most vital research tool for basic and applied research in the field of biomedical sciences and continues to develop swiftly. A growing collection of gene technology, and sequencing of the rat genome and biological conservation, place rats at the top position as a model to translate mechanisms underlying human disease progression. As a model of human disease, rat model offer a many advantages over the mouse and other related organisms. The rat is an excellent model for cardiovascular disease, predominantly for stroke and hypertension. The physiology of rat model is easier to monitor and, over time, a volume of data has developed that will take years to be replicated in the mouse. Moreover, in many cases, the physiology is more like the equivalent to human condition. The combined approaches of embryonic stem cell (ES) technologies and insertional and chemical mutagenesis have grown rat models application beyond the conventional limits. Major factor boosting the growth of the global rat model market is the growing application of rat models not only in the field of basic research, but also in applied field of drug development and discovery. Rat model applications in drug discovery include development of new therapeutic strategies for the treatment of human diseases, target identification and validation, drug screening and lead optimization, and toxicity and safety screening which in turn is boosting the demand for rat model market. On the other hand, factors such as stringent regulatory framework that require precise control on use of animals in laboratories, rising concern on animal cruelty, and ethical concerns over the use of animals could negatively impact market growth.
The rat model market is broadly segmented on the basis of type, application and by services. The rat model market by type includes hybrid rats, outbred rats, inbred rats, immnuodeficient rats, transgenic and surgically modified rat models. The outbred rats held the largest share in the rat model market owing to the extensive application of toxicology. By application, the market has been segmented into immunology, oncology, central nervous system, cardiovascular, diabetes, and metabolism & regulation. By services, the rat model is segmented as breeding, cryopreservation, quarantine, rederivation, genetic testing, and in vivo and in vitro pharmacology services. The cryopreservation segment is expected to grow at the highest rate as it requires less investment to maintain rat strain for a longer time.
Geographically, the global rat model market has been categorized into North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America held the largest share in the rat model market. The dominance of the region is majorly due to the robust research activities for the development of drugs and biologics and presence of major pharmaceutical and biotechnology companies in the region. Europe had the second largest share in the global rat model market. Germany was the leading country in Europe. Asia Pacific is expected to be the fastest growing market for the rat model during the forecast period from 2015 to 2023. This high growth is primarily due to the increasing number of academic and contract research organizations in Japan, China, Australia, and India which shows an immense opportunities to companies in the rat model market. The market in Latin America and Rest of the World would witness a significant growth due to increasing public and private investment in biomedical researches, rising awareness, and flexible regulatory scenario.
Some of the major players operating in global rat model market are Charles River Laboratories, Biomedical Research Models, Inc., Covance, Inc., genOway S.A., Harlan Laboratories, Inc., SAGE Labs, Transviragen Inc., Transposagen Biopharmaceuticals, Inc. and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.